Literature DB >> 29760215

Specific Binding to Differentially Expressed Human Carcinoembryonic Antigen-Related Cell Adhesion Molecules Determines the Outcome of Neisseria gonorrhoeae Infections along the Female Reproductive Tract.

Epshita A Islam1, Varun C Anipindi2, Ian Francis3, Yazdan Shaik-Dasthagirisaheb3, Stacey Xu1, Nelly Leung1, Anna Sintsova1, Mohsen Amin1, Charu Kaushic2, Lee M Wetzler3, Scott D Gray-Owen4.   

Abstract

The gonococcal Opa proteins are an antigenically variable family of surface adhesins that bind human carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1), CEACAM3, CEACAM5, and/or CEACAM6, cell surface glycoproteins that are differentially expressed on a broad spectrum of human cells and tissues. While they are presumed to be important for infection, the significance of various Opa-CEACAM-mediated cellular interactions in the context of the genital tract has remained unclear. Here, we observed that CEACAM1 and CEACAM5 are differentially expressed on epithelia lining the upper and lower portions of the human female genital tract, respectively. Using transgenic mouse lines expressing human CEACAMs in a manner that reflects this differential pattern, we considered the impact of Opa-CEACAM interactions during uncomplicated lower genital tract infections versus during pelvic inflammatory disease. Our results demonstrate that Opa-CEACAM5 binding on vaginal epithelia facilitates the long-term colonization of the lower genital tract, while Opa protein binding to CEACAM1 on uterine epithelia enhances gonococcal association and penetration into these tissues. While these Opa-dependent interactions with CEACAM-expressing epithelial surfaces promote infection, Opa binding by neutrophil-expressed CEACAMs counterbalances this by facilitating more effective gonococcal clearance. Furthermore, during uterine infections, CEACAM-dependent tissue invasion aggravates disease pathology by increasing the acute inflammatory response. Together, these findings demonstrate that the outcome of infection is determined by both the cell type-specific expression of human CEACAMs and the CEACAM specificity of the Opa variants expressed, which combine to determine the level of gonococcal association with the genital mucosa versus the extent of CEACAM-dependent inflammation and gonococcal clearance by neutrophils.
Copyright © 2018 American Society for Microbiology.

Entities:  

Keywords:  CEACAM1; Neisseria gonorrhoeae; carcinoembryonic antigen (CEA); carcinoembryonic antigen-related cellular adhesion molecules (CEACAM); gonorrhea; inflammation; mucosal infection; pelvic inflammatory disease (PID); sexually transmitted disease (STD)

Mesh:

Substances:

Year:  2018        PMID: 29760215      PMCID: PMC6056862          DOI: 10.1128/IAI.00092-18

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  47 in total

1.  Opposing selective forces for expression of the gonococcal lactoferrin receptor.

Authors:  James E Anderson; Marcia M Hobbs; Gour D Biswas; P Frederick Sparling
Journal:  Mol Microbiol       Date:  2003-06       Impact factor: 3.501

2.  CEACAM1 inhibits Toll-like receptor 2-triggered antibacterial responses of human pulmonary epithelial cells.

Authors:  Hortense Slevogt; Solveig Zabel; Bastian Opitz; Andreas Hocke; Julia Eitel; Philippe D N'guessan; Lothar Lucka; Kristian Riesbeck; Wolfgang Zimmermann; Janine Zweigner; Bettina Temmesfeld-Wollbrueck; Norbert Suttorp; Bernhard B Singer
Journal:  Nat Immunol       Date:  2008-10-05       Impact factor: 25.606

3.  The N-domain of the human CD66a adhesion molecule is a target for Opa proteins of Neisseria meningitidis and Neisseria gonorrhoeae.

Authors:  M Virji; S M Watt; S Barker; K Makepeace; R Doyonnas
Journal:  Mol Microbiol       Date:  1996-12       Impact factor: 3.501

4.  Human C4b-binding protein selectively interacts with Neisseria gonorrhoeae and results in species-specific infection.

Authors:  Jutamas Ngampasutadol; Sanjay Ram; Anna M Blom; Hanna Jarva; Ann E Jerse; Egil Lien; Jon Goguen; Sunita Gulati; Peter A Rice
Journal:  Proc Natl Acad Sci U S A       Date:  2005-11-07       Impact factor: 11.205

5.  Neisseria gonorrhoeae pilin glycan contributes to CR3 activation during challenge of primary cervical epithelial cells.

Authors:  Michael P Jennings; Freda E-C Jen; Louise F Roddam; Michael A Apicella; Jennifer L Edwards
Journal:  Cell Microbiol       Date:  2011-03-04       Impact factor: 3.715

6.  Distinct proinflammatory host responses to Neisseria gonorrhoeae infection in immortalized human cervical and vaginal epithelial cells.

Authors:  R N Fichorova; P J Desai; F C Gibson; C A Genco
Journal:  Infect Immun       Date:  2001-09       Impact factor: 3.441

7.  Human-like immune responses in CD46 transgenic mice.

Authors:  Linda Johansson; Anne Rytkönen; Hong Wan; Peter Bergman; Laura Plant; Birgitta Agerberth; Tomas Hökfelt; Ann-Beth Jonsson
Journal:  J Immunol       Date:  2005-07-01       Impact factor: 5.422

8.  Selection for a CEACAM receptor-specific binding phenotype during Neisseria gonorrhoeae infection of the human genital tract.

Authors:  Anna Sintsova; Henry Wong; Kelly S MacDonald; Rupert Kaul; Mumtaz Virji; Scott D Gray-Owen
Journal:  Infect Immun       Date:  2015-01-20       Impact factor: 3.441

9.  A new confirmatory Neisseria gonorrhoeae real-time PCR assay targeting the porA pseudogene.

Authors:  D M Whiley; P J Buda; J Bayliss; L Cover; J Bates; T P Sloots
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-07-10       Impact factor: 3.267

10.  The reproductive cycle is a pathogenic determinant during gonococcal pelvic inflammatory disease in mice.

Authors:  E A Islam; Y Shaik-Dasthagirisaheb; C Kaushic; L M Wetzler; S D Gray-Owen
Journal:  Mucosal Immunol       Date:  2015-12-23       Impact factor: 7.313

View more
  14 in total

Review 1.  Gonococcal Defenses against Antimicrobial Activities of Neutrophils.

Authors:  Allison Palmer; Alison K Criss
Journal:  Trends Microbiol       Date:  2018-08-13       Impact factor: 17.079

Review 2.  Gonococcal Pelvic Inflammatory Disease: Placing Mechanistic Insights Into the Context of Clinical and Epidemiological Observations.

Authors:  Stacey X Xu; Scott D Gray-Owen
Journal:  J Infect Dis       Date:  2021-08-16       Impact factor: 7.759

3.  Preclinical Testing of Vaccines and Therapeutics for Gonorrhea in Female Mouse Models of Lower and Upper Reproductive Tract Infection.

Authors:  Kristie L Connolly; Michelle Pilligua-Lucas; Carolina Gomez; Allison C Costenoble-Caherty; Anthony Soc; Knashka Underwood; Andrew N Macintyre; Gregory D Sempowski; Ann E Jerse
Journal:  J Infect Dis       Date:  2021-08-16       Impact factor: 7.759

4.  Mutated CEACAMs Disrupt Transforming Growth Factor Beta Signaling and Alter the Intestinal Microbiome to Promote Colorectal Carcinogenesis.

Authors:  Shoujun Gu; Sobia Zaidi; Md Imtaiyaz Hassan; Taj Mohammad; Tathiane M Malta; Houtan Noushmehr; Bryan Nguyen; Keith A Crandall; Jigisha Srivastav; Vincent Obias; Paul Lin; Bao-Ngoc Nguyen; Michael Yao; Ren Yao; Charles Hadley King; Raja Mazumder; Bibhuti Mishra; Shuyun Rao; Lopa Mishra
Journal:  Gastroenterology       Date:  2019-10-01       Impact factor: 22.682

Review 5.  CEACAM1 in Liver Injury, Metabolic and Immune Regulation.

Authors:  Andrea Kristina Horst; Sonia M Najjar; Christoph Wagener; Gisa Tiegs
Journal:  Int J Mol Sci       Date:  2018-10-11       Impact factor: 5.923

Review 6.  Progress Toward a Gonococcal Vaccine: The Way Forward.

Authors:  Michael W Russell; Ann E Jerse; Scott D Gray-Owen
Journal:  Front Immunol       Date:  2019-10-15       Impact factor: 7.561

7.  Unaltered Fungal Burden and Lethality in Human CEACAM1-Transgenic Mice During Candida albicans Dissemination and Systemic Infection.

Authors:  Esther Klaile; Mario M Müller; Cristina Zubiría-Barrera; Saskia Brehme; Tilman E Klassert; Magdalena Stock; Adrian Durotin; Tien D Nguyen; Sabina Feer; Bernhard B Singer; Peter F Zipfel; Sven Rudolphi; Ilse D Jacobsen; Hortense Slevogt
Journal:  Front Microbiol       Date:  2019-11-26       Impact factor: 5.640

8.  The serogroup B meningococcal outer membrane vesicle-based vaccine 4CMenB induces cross-species protection against Neisseria gonorrhoeae.

Authors:  Isabelle Leduc; Kristie L Connolly; Afrin Begum; Knashka Underwood; Stephen Darnell; William M Shafer; Jacqueline T Balthazar; Andrew N Macintyre; Gregory D Sempowski; Joseph A Duncan; Marguerite B Little; Nazia Rahman; Eric C Garges; Ann E Jerse
Journal:  PLoS Pathog       Date:  2020-12-08       Impact factor: 6.823

9.  Bacterial protein domains with a novel Ig-like fold target human CEACAM receptors.

Authors:  Nina M van Sorge; Daniel A Bonsor; Liwen Deng; Erik Lindahl; Verena Schmitt; Mykola Lyndin; Alexej Schmidt; Olof R Nilsson; Jaime Brizuela; Elena Boero; Eric J Sundberg; Jos A G van Strijp; Kelly S Doran; Bernhard B Singer; Gunnar Lindahl; Alex J McCarthy
Journal:  EMBO J       Date:  2021-02-01       Impact factor: 11.598

10.  Neisseria gonorrhoeae infects the heterogeneous epithelia of the human cervix using distinct mechanisms.

Authors:  Qian Yu; Liang-Chun Wang; Sofia Di Benigno; Scott D Gray-Owen; Daniel C Stein; Wenxia Song
Journal:  PLoS Pathog       Date:  2019-12-02       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.